Spin-Off of Theravance Biopharma, Inc. (Tables)

12 Months Ended

Dec. 31, 2014

Spin-Off of Theravance Biopharma, Inc.

Schedule of net book value of assets that were contributed in connection with the Spin-Off

(In thousands)	June 2, 2014
Cash and cash equivalents	$	277,541
Marketable investment securities		115,129
Accounts receivable		125
Reimbursement of certain liabilities		16,983
Prepaid and other current assets		3,172
Inventories		14,328
Fixed assets, net		9,580
Accrued liabilities		(22,342	)
Deferred revenue		(6,694	)
Other liabilities		(4,944	)
Net book value of assets contributed	$	402,878